133 related articles for article (PubMed ID: 2754703)
1. 31P NMR studies of the kinetics of bisalkylation by isophosphoramide mustard: comparisons with phosphoramide mustard.
Boal JH; Williamson M; Boyd VL; Ludeman SM; Egan W
J Med Chem; 1989 Aug; 32(8):1768-73. PubMed ID: 2754703
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protonation of isophosphoramide mustard and phosphoramide mustard.
Millis KK; Colvin ME; Shulman-Roskes EM; Ludeman SM; Colvin OM; Gamcsik MP
J Med Chem; 1995 Jun; 38(12):2166-75. PubMed ID: 7783148
[TBL] [Abstract][Full Text] [Related]
3. Direct detection of the intracellular formation of carboxyphosphamides using nuclear magnetic resonance spectroscopy.
Boal JH; Ludeman SM; Ho CK; Engel J; Niemeyer U
Arzneimittelforschung; 1994 Jan; 44(1):84-93. PubMed ID: 8135883
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacokinetics and stability of isophosphoramide mustard.
Zheng JJ; Chan KK; Muggia F
Cancer Chemother Pharmacol; 1994; 33(5):391-8. PubMed ID: 8306413
[TBL] [Abstract][Full Text] [Related]
5. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
6. 1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.
Springer JB; Chang YH; Koo KI; Colvin OM; Colvin ME; Dolan ME; Delaney SM; Flowers JL; Ludeman SM
Chem Res Toxicol; 2004 Sep; 17(9):1217-26. PubMed ID: 15377155
[TBL] [Abstract][Full Text] [Related]
7. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
[TBL] [Abstract][Full Text] [Related]
8. 31P NMR and chloride ion kinetics of alkylating monoester phosphoramidates.
Fries KM; Borch RF
J Med Chem; 1991 Feb; 34(2):565-9. PubMed ID: 1995878
[TBL] [Abstract][Full Text] [Related]
9. Protonation of phosphoramide mustard and other phosphoramides.
Gamcsik MP; Ludeman SM; Shulman-Roskes EM; McLennan IJ; Colvin ME; Colvin OM
J Med Chem; 1993 Nov; 36(23):3636-45. PubMed ID: 8246232
[TBL] [Abstract][Full Text] [Related]
10. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
[TBL] [Abstract][Full Text] [Related]
11. Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
Kallama S; Hemminki K
Chem Biol Interact; 1986 Jan; 57(1):85-96. PubMed ID: 3948286
[TBL] [Abstract][Full Text] [Related]
12. 31P NMR kinetic studies of the intra- and intermolecular alkylation chemistry of phosphoramide mustard and cognate N-phosphorylated derivatives of N,N-bis(2-chloroethyl)amine.
Engle TW; Zon G; Egan W
J Med Chem; 1982 Nov; 25(11):1347-57. PubMed ID: 7143373
[No Abstract] [Full Text] [Related]
13. Assessment of glucosylifosfamide mustard biodistribution in rats with prostate adenocarcinomas by means of in vivo 31P NMR and in vitro uptake experiments.
Haberkorn U; Krems B; Gerlach L; Bachert P; Morr I; Wiessler M; van Kaick G
Magn Reson Med; 1998 May; 39(5):754-61. PubMed ID: 9581607
[TBL] [Abstract][Full Text] [Related]
14. Further studies on the conversion of 4-hydroxyoxazaphosphorines to reactive mustards and acrolein in inorganic buffers.
Low JE; Borch RF; Sladek NE
Cancer Res; 1983 Dec; 43(12 Pt 1):5815-20. PubMed ID: 6640533
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of phosphoramide mustard hydrolysis in aqueous solution.
Watson E; Dea P; Chan KK
J Pharm Sci; 1985 Dec; 74(12):1283-92. PubMed ID: 4087195
[TBL] [Abstract][Full Text] [Related]
17. 31P NMR investigations of phosphoramide mustard: evaluation of pH control over the rate of intramolecular cyclization to an aziridinium ion and the hydrolysis of this reactive alkylator.
Engle TW; Zon G; Egan W
J Med Chem; 1979 Aug; 22(8):897-9. PubMed ID: 40026
[No Abstract] [Full Text] [Related]
18. Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells.
Smith SM; Ludeman SM; Wilson LR; Springer JB; Gandhi MC; Dolan ME
Cancer Chemother Pharmacol; 2003 Oct; 52(4):291-302. PubMed ID: 12845477
[TBL] [Abstract][Full Text] [Related]
19. Identification of new aqueous chemical degradation products of isophosphoramide mustard.
Breil S; Martino R; Gilard V; Malet-Martino M; Niemeyer U
J Pharm Biomed Anal; 2001 Jun; 25(3-4):669-78. PubMed ID: 11377048
[TBL] [Abstract][Full Text] [Related]
20. Chemical stability and fate of the cytostatic drug ifosfamide and its N-dechloroethylated metabolites in acidic aqueous solutions.
Gilard V; Martino R; Malet-Martino M; Niemeyer U; Pohl J
J Med Chem; 1999 Jul; 42(14):2542-60. PubMed ID: 10411475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
